TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

SALIX

ImmunologyGastroenterologyOncology
Specialty

SALIX is a specialty pharmaceutical company focused on Immunology, Gastroenterology, Oncology. Key products include TRULANCE.

2004
Since
7
Drugs
-
Trials
2
Approved (2yr)

Key Drugs

TRULANCE
plecanatide
Guanylate Cyclase C 2 indications · 2017
UCERIS
budesonide
Immunology
1 indications · 2013
PLENVU
ascorbic acid
· 2018

Recent Activity

FENOGLIDE 2025-06-06
Labeling
UCERIS 2024-06-05
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 40%
2 drugs
Gastroenterology 40%
2 drugs
Oncology 20%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Oncology, Immunology, Gastroenterology
Bristol-Myers Squibb big-pharma
Oncology, Immunology, Gastroenterology
Takeda big-pharma
Immunology, Oncology, Gastroenterology
Gilead Sciences biotech
Oncology, Immunology, Gastroenterology
ASTELLAS specialty
Oncology, Gastroenterology, Immunology